The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in u.s. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts).
 
Tom Stinchcombe
Consulting or Advisory Role - Abbvie; ARIAD; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Helsinn Therapeutics; Lilly
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Merck Serono (Inst); Threshold Pharmaceuticals (Inst)
 
Ying J Zhang
No Relationships to Disclose
 
Everett E. Vokes
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx
 
Joan H. Schiller
Consulting or Advisory Role - Abbvie; Agennix; Argole Systems; ARIAD; AVEO; Biodesix; Boehringer Ingelheim; Clovis Oncology; Dekkun Corporation; Eisai; Genentech; Genentech/Roche; Lilly; Merck; Synta
Research Funding - Astex Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Endocyte (Inst); Genentech (Inst); Johnson & Johnson (Inst); Merrimack (Inst); Merrimack (Inst); Novartis (Inst); Synta (Inst); Synta (Inst); Synta (Inst)
Travel, Accommodations, Expenses - Biodesix
Other Relationship - Free to Breathe
 
Jeffrey D. Bradley
Research Funding - Mevion Medical Systems (Inst); ViewRay (Inst)
 
Walter John Curran
Stock and Other Ownership Interests - eviti; Nanthealth
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone
Consulting or Advisory Role - eviti
Research Funding - Abbvie (Inst)
 
Benjamin Movsas
Research Funding - Philips Healthcare (Inst); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Lung phantom for image guidance; MR-CT imaging related patent for radiation oncology
Travel, Accommodations, Expenses - Varian Medical Systems
 
Steven E. Schild
No Relationships to Disclose
 
Gerald H. Clamon
No Relationships to Disclose
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Bayer; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Novartis
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Merck
 
George R. Blumenschein
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Merck
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst); Novartis (Inst); Xcovery (Inst)
 
Mark A. Socinski
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst)
 
Neal Ready
Honoraria - Bristol-Myers Squibb; Celgene; Heat Biologics
Travel, Accommodations, Expenses - AstraZeneca
 
Wallace L. Akerley
No Relationships to Disclose
 
Harvey Jay Cohen
No Relationships to Disclose
 
Herbert Pang
No Relationships to Disclose
 
Xiaofei F. Wang
No Relationships to Disclose